#USA #Toronto #Myant #Arab Health #Disease Prevention

Myant's Role in Shaping Future Healthcare

In an era where healthcare innovation is paramount, Myant emerges as a trailblazer at the Arab Health 2025 conference. This event serves as the most significant healthcare gathering in the Middle East where key players in the sector connect, and Myant is ready to unveil a future where disease prevention is achieved through intelligent technologies.

Pioneering Human-Centric Care

Myant's mission is rooted in enabling human-centric, precise, and preventive care through continuous data connection. The company is set to demonstrate this vision with the introduction of its Myant Care platform. This platform integrates various health data to predict and prevent diseases, ensuring that populations stay healthy with early warnings and timely interventions. With Myant Care, clinical-grade interfaces are employed to facilitate real medical decisions, transforming continuous health data and scientific literature into actionable care plans.

Skiin Generation 2: Innovation at Its Best

At the heart of Myant’s offerings lies Skiin Generation 2, described as the world's first comfortable, passive remote monitor that prioritizes the user experience. This FDA-approved device is revolutionary, combining ECG, cuffless blood pressure, breathing patterns, core body temperature, SpO2 levels, and sleep metrics. Such comprehensive monitoring not only enhances the diagnosis and management of chronic conditions but also empowers healthcare professionals with real-time telemetry during virtual consultations, effectively bridging the gap between reactive and proactive care.

Building Strategic Alliances

Participating at Arab Health 2025 in the Ontario Pavilion, Myant aligns with the Ontario Government's Life Sciences Export Mission. This initiative aims to foster strategic partnerships throughout the Gulf Cooperational Council (GCC) region. Myant’s presence is not just about showcasing their products; it represents their commitment to establishing a strong foothold in the Middle East, reinforcing Ontario’s reputation as a leader in cutting-edge life sciences innovation.

Funding for Expansion

During the event, Myant plans to announce a Series C funding round of $250 million to increase its reach to one million patients. This ambitious goal exemplifies Myant's dedication to harnessing advanced technologies and strategic growth to facilitate healthy living and improve global health outcomes.

About Myant Corp

Founded with the goal of improving quality of life for all, Myant Corp leverages advancements in AI, medicine, and innovative materials to ensure health, safety, connection, and peace of mind at every life stage. By introducing AI guardians within their textile interfaces, they create a second skin that seamlessly integrates into daily life, setting a new benchmark for interaction with the digital world.

In 2024, Myant expanded significantly within the EU and appointed Dr. Xin Gao, a globally renowned AI scientist, as their Chief AI Officer. Dr. Gao's expertise is anticipated to further propel Myant’s innovations in disease prevention, emphasizing the company’s commitment to the confluence of AI and healthcare.

Visit Myant at Arab Health from January 27-30, 2025, at the Ontario Pavilion, Booth H7.B50, in the Dubai World Trade Center, and experience firsthand how they are shaping the future of healthcare for generations to come. For further details, visit www.myant.ca.